Table 2.
Characteristic [number (%) with available information]b | HPV vaccine initiationa | |||
---|---|---|---|---|
Yes | No | |||
Numberc | Weighted % (95% CI) | Numberc | Weighted % (95% CI) | |
Age | ||||
13–17 years [120 (95.2%)] | 82 | 70.7 (61.6, 79.9) | 38 | 29.3 (20.1, 38.5) |
11–17 years [170 (94.4%)] | 99 | 63.2 (55.1, 71.3) | 71 | 36.8 (28.7, 44.9) |
9–17 years [246 (94.6%)] | 111 | 51.8 (44.7, 58.9) | 135 | 48.2 (41.1, 55.3) |
Sexd | ||||
Female [60 (92.3%)] | 45 | 76.4 (64.0, 88.9) | 15 | 23.6 (11.1, 36.0) |
Male [59 (98.3%)] | 37 | 66.4 (52.9, 80.0) | 22 | 33.6 (20.0, 47.1) |
CI confidence interval, HPV human papillomavirus
aHPV vaccine initiation is defined as American Indian adolescents who have received at least one dose of the HPV vaccine
bAvailable information does not include missing values and “don’t know” response to the question: “Has your child ever received an HPV shot or vaccine?”
cUnweighted counts represent the actual number of respondents in the survey sample
dAmong adolescents aged 13–17 years